Currently, we are focused on Trimethylaminuria, Phenylketonuria and other metabolic conditions. Due to the rarity, lack of awareness, and lack of funding, these diseases and medical conditions have been the focus of our organization. We're currently working with the FDA, INVIMA, Florida State University, and other companies and institutions around the world to research and develop solutions for these diseases.